AMLX vs CMS · rev $87.4M vs P/E 20, $22.42B cap
Amylyx Pharmaceuticals Inc (AMLX) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
CMS does not have a complete income-statement cache yet.
AMLX currently screens at market cap $561.6M. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the AMLX and CMS stock pages for the full models.
Not investment advice.